EATG » News

All EATG annual reports on one page

No more bulky printed booklets or large PDF files - view and read all EATG annual reports from the last four years on this page: https://www.eatgannualreport.com/ EATG has been working to…

EATG signed on TAG call for TB research for pregnant women

EATG signed a call initiated by Treatment Action Group (TAG, US) for support TB research for pregnant women that is addressed to the Task Force on Research Specific to Pregnant and…

New results from Flash! PrEP in Europe released at IAS 2017

Paris, 26 July: AIDES and PLUS announced to conference attendees from the world over results from the biggest European survey ever to be conducted regarding knowledge, interest and utilisation of…

IAS2017 – Community Paris Declaration published

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the fight against HIV. This is sometimes a scientific announcement (the arrival…

Lay Summaries workshop: Report now out!

Today the results from clinical trials are usually discussed within the scientific community only and are seldom spread to the general public. With the release of the EU Clinical Trials…

1st Interim Meeting for ESTICOM

EATG participated in the 1st Interim Meeting of the ESTICOM project (http://www.esticom.eu) in Brussels on 17-18/7. ESTICOM is, to some extent, the continuation and revision of the much-used and very useful…

EATG Project Management and Evaluation Webinars – All you need

EATG organised a series of webinars on the management, evaluation and monitoring of projects in advocacy. Hosted and presented by EATG member and social science researcher Ian Hodgson, the webinars…

Apply now! STEPS – Cure Workshop at the EACS Conference in Milan

If you are planning to attend the EACS meeting in Milan, Italy (October 25-27, 2017), you are invited to apply to attend the fourth community meeting on HIV cure, therapeutic…

Call for applications: European HIV Academy for Enabling Legal Environments

European HIV Academy for Enabling Legal Environments 13-14 September 2017 Venue: Deutsche AIDS Hilfe (DAH), Berlin, Germany Apply here: https://www.surveymonkey.com/r/WZRFV35 Applications will close on 26 July 2017 (23:59 CET)  …

Webinar: IP barriers to affordable quality medicines

EATG will host a community oriented webinar on intellectual property (IP) barriers to affordable quality medicines and ways in which these can be addressed on 12 July from 12:00 to…

EATG is concerned by the Cochrane review of DAA treatment against HCV infection

Direct acting agents used against hepatitis C infection are clinically effective and reliable. EATG, the pan-European network of communities of people living with and affected by hepatitis C (HCV) and…

EATG joins new coalition calling on EU to take action to eliminate viral hepatitis by 2030

Launched at an event in the European Parliament on 7 June 2017, the ACHIEVE (short for Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe) coalition calls…

EATG Tuberculosis Team met Belgian Senate

  On May 15, EATG and TBpeople, EECA network of people with tuberculosis with support from the Stop TB Partnership, convened a meeting at the Belgian Senate to raise political awareness to…

EUPATI webinar: Guidance for patient involvement in ethical review of clinical trials

EUPATI will host a webinar, Guidance for patient involvement in ethical review of clinical trials on 29 May 2017 from 17:00 to 18:30 CET. For more information about the webinar and how…

HepHIV 2017 Conference call to action and proceedings

The HepHIV 2017 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care was held by HIV in Europe, in collaboration with European stakeholders, from 31 January - 2…

EmERGE newsletter, May 2017

EmERGE is a project funded by the European Union’s Horizon 2020 Research and Innovation Programme. EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease.…

Stephan Dressler’s presentation on hepatitis B treatment

EATG held an interesting and successful ECAB meeting on viral hepatitis treatment and research in Tbilisi, Georgia in December 2016. The report on the meeting was published previously. This presentation…

ECDC Malta Conference Report Now Out

ECDC has announced on 04/05/2017 the finalisation and  and publication of the notes of the important Malta Presidency HIV Conference (Fast-tracking the end of AIDS in Europe – practical evidence-based interventions) held…

CoPE – Special Round of Applications! Apply Now!

We are pleased to announce a special call for CoPE applications, addressing the specific needs of migrant communities in the European and Central Asian region. This call supports the translation…

Hepatitis C Civil Society Declaration launched

At the Hepatitis C Community Summit held on 18-19 April 2017 in Amsterdam, civil society and community organisations from all over Europe launched a declaration to address the urgent need…

Gilead loss of generic HIV drug battle a boost for gay community in Ireland

Generic versions of Truvada that are 60 per cent cheaper are about to hit Irish market A campaign by Ireland’s gay and transgender community for access to cheaper drugs to…

Scientists find missing clue to how HIV hacks cells to propagate itself

Computer modeling has helped a team of scientists, including several scholars from the University of Chicago, to decode previously unknown details about the process by which HIV forces cells to…

Undetectable = Untransmittable: a community brief

The International Council of AIDS Service Organizations (ICASO) developed a brief to provide the HIV community with current information and analysis of new and updated clinical data on the effectiveness…

Advances in HIV prevention, treatment and cure: a special issue of PLOS Medicine

Senior Editor Richard Turner discusses the content published in week 1 of the PLOS Medicine Special Issue on HIV/AIDS. This week, PLOS Medicine begins publication of a Special Issue on…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 323 of the “Global Fund Observer.” The newsletter includes articles…

HIV remission: the quest to turn lessons from exceptional cases into solutions

The case of an HIV-infected child in South Africa who has been in remission for nearly nine years without taking any antiretroviral drugs has provided further proof that HIV remission…

HIV patients at greater risk of both heart and kidney disease

HIV patients and their doctors are urged to be more aware of the additional health risks associated with treated HIV infection. This follows new research that shows HIV patients at…

Study finds no evidence raltegravir-based ART regimen leads to cancer or death

A crucial step in the propagation of the HIV is the integration of viral nucleic acids into the host genome. This process occurs with the help of the HIV-1 integrase…

People with HIV more likely to adhere to their antiretroviral therapy than treatment for other chronic health problems

Ageing HIV-positive people have significantly higher levels of adherence to their antiretroviral therapy than to medication taken for other chronic health problems, Swiss investigators report in HIV Medicine. The research…

HIV diagnoses in English gay men have been falling since 2014

A new analysis by Public Health England of testing rates and HIV diagnoses from all of England’s sexual health clinics shows that the decline in diagnoses is England-wide, started at…

High HIV incidence from non-primary partners and low PEP and PrEP use seen in PARTNER study

HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside the main relationship, was high, and very high in partners…

European AIDS Clinical Society strengthens HPV vaccination advice

New European guidance responds to growing evidence of anal cancer risk in HIV-positive men who have sex with men The European AIDS Clinical Society (EACS) has recommended HPV (human papillomavirus)…

HIV patients live longer, require intricate geriatric care

DALLAS - HIV adds to the typical health concerns that affect people as they age, and with fewer people dying of AIDS, healthcare providers are facing more complicated geriatric cases.…

Promising new drug for hepatitis B tested

Promising new drug for hepatitis B tested at Texas Biomedical Research Institute San Antonio, Texas (November 7, 2017) – Research at the Southwest National Primate Research Center (SNPRC) on the…

Scratching the surface of mature monocytes…and coming up with CXCR7

New research in the Journal of Leukocyte Biology reveals potential therapeutic target to reduce brain inflammation in disease New research published online in the Journal of Leukocyte Biology showed for…

Clues to body’s defense against common oral ailment

ACHIEVE Coalition sends open letter to Romanian MoH

The ACHIEVE Coalition sent this open letter to the Minister of Health of Romania today. The letter, co-signed by EATG as a member of ACHIEVE, calls the Romanian government to…

Worldwide 52 million children living with viral hepatitis

New data presented at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) show that 52 million children are living with viral hepatitis worldwide, compared to 2.1 million…

Hepatitis C buyers’ clubs grow worldwide as a way to obtain affordable treatment

Hidden amongst the thousands of Facebook pages given over to holiday snaps and gossip are groups of patients who have hepatitis C, a disease that affects more than 70 million…

For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials. Read the full publication here.